Breast Cancer Risk Lingered Years after Women Discontinued Estrogen-Progestin Therapy
 

A follow-up study of postmenopausal women who took the combination of estrogen and progestin for more than five years as part of the landmark Women ' s Health Initiative shows that the women continued to face an increased risk for breast cancer nearly three years after they quit taking the hormones.

More...